CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

Clinton Yam, Mien Chie Hung, Gabriel N. Hortobagyi

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?'. Together they form a unique fingerprint.